RxDoctor Payments Data

Kevin Smith, MD

Pain Medicine · San Diego, CANPI 1457388225

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,082 of the $6,832 with a category attached, or 89.0%. 12 manufacturers reported payments, led by Medtronic at 51.7% of the total. Reporting peaked in 2024 at $1,861 and has fallen 78.7% since, to $397 in 2025.

$6,832in general payments, 2019–2025

Across 138 payments — averaging $49.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Intuitive Surgical$766
  • Boston Scientific$701
  • Abbott$565
  • Nevro Corp.$364
  • Flowonix Medical Incorporated$268
  • plus $638 from 6 others
$73,211in research payments, 2019–2025

Across 34 payments — averaging $2153.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$73K

What the payments were for

  • Food & beverage$6,08289%
  • Education$75011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,832 in reported general payments places this provider in the 75th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Medicare billing

Part B allowed, 2024
$252,203
Medicare patients
173
Services billed
24,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen49$2,833
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$1,955
Oxycodone Hcl55$1,335
Morphine Sulfate ErMorphine Sulfate28$593
Pregabalin20$379
Tizanidine Hcl12$261
Diazepam13$81
Latanoprost11$33

Paid to pharmacies, not to this prescriber.

Other pain medicine in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →